Expressing support for the designation of March 3, 2025, as "National Triple-Negative Breast Cancer Day". | ChamberLight
Bills · HRES 182
IN COMMITTEE· 119TH CONGRESS
House Res.HRES 182Health
Expressing support for the designation of March 3, 2025, as "National Triple-Negative Breast Cancer Day".
INTRO MAR 3· LAST ACTION MAR 3
READING
1MIN
COSPONSORS
0
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
Non-binding
LEGISLATIVE PROGRESS
STEP 2 / 8
Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-written
Americans most directly affected by this resolution are those currently battling triple-negative breast cancer (TNBC), their families, friends, and caregivers. While the resolution doesn't provide direct services or funding, increased public awareness could lead to greater understanding and support for these individuals. Additionally, medical researchers and healthcare professionals focused on breast cancer, especially TNBC, might see benefits from a nationally recognized day as it could encourage more discussions, fundraising, and focus on the disease.
Specific groups highlighted in the resolution, such as young women, Black and Hispanic women, and individuals with BRCA gene mutations, who are disproportionately affected by TNBC, would also be among those whose experiences are brought to the forefront by such a designation.
KEY PROVISIONS
3AI-extracted
PROVISION 01
The House of Representatives expresses its formal support for designating March 3, 2025, as "National Triple-Negative Breast Cancer Day."
This provision aims to create a dedicated day for public awareness of this aggressive form of breast cancer.
PROVISION 02
The resolution highlights that triple-negative breast cancer is a distinct and aggressive type, accounting for 10-15% of all breast cancer diagnoses and 25% of all breast cancer deaths.
This provides important context and data to justify the need for increased awareness about TNBC.
PROVISION 03
It acknowledges that triple-negative breast cancer disproportionately affects young women, Black and Hispanic women, and those with BRCA gene mutations.
This draws attention to specific populations that bear a heavier burden from this disease, potentially encouraging targeted outreach and research.
Americans most directly affected by this resolution are those currently battling triple-negative breast cancer (TNBC), their families, friends, and caregivers. While the resolution doesn't provide direct services or funding, increased public awareness could lead to greater understanding and support for these individuals. Additionally, medical researchers and healthcare professionals focused on breast cancer, especially TNBC, might see benefits from a nationally recognized day as it could encourage more discussions, fundraising, and focus on the disease.
Specific groups highlighted in the resolution, such as young women, Black and Hispanic women, and individuals with BRCA gene mutations, who are disproportionately affected by TNBC, would also be among those whose experiences are brought to the forefront by such a designation.
KEY PROVISIONS
AI-extracted
med
The House of Representatives expresses its formal support for designating March 3, 2025, as "National Triple-Negative Breast Cancer Day."
This provision aims to create a dedicated day for public awareness of this aggressive form of breast cancer.
high
The resolution highlights that triple-negative breast cancer is a distinct and aggressive type, accounting for 10-15% of all breast cancer diagnoses and 25% of all breast cancer deaths.
This provides important context and data to justify the need for increased awareness about TNBC.
high
It acknowledges that triple-negative breast cancer disproportionately affects young women, Black and Hispanic women, and those with BRCA gene mutations.
This draws attention to specific populations that bear a heavier burden from this disease, potentially encouraging targeted outreach and research.
Proposed date for "National Triple-Negative Breast Cancer Day"
GLOSSARY
AI-written
Resolution
A legislative measure that expresses the opinion or will of one or both chambers of Congress but does not have the force of law.
Triple-Negative Breast Cancer (TNBC)
A specific and aggressive type of breast cancer that does not have estrogen receptors, progesterone receptors, or an excess of the HER2 protein. This makes it distinct from other breast cancers and often harder to treat with targeted hormone therapies.
Estrogen Receptor-negative
Refers to cancer cells that do not have proteins (receptors) that bind to the hormone estrogen. This means treatments that block estrogen are unlikely to be effective.
Progesterone Receptor-negative
Refers to cancer cells that do not have proteins (receptors) that bind to the hormone progesterone. This means treatments that block progesterone are unlikely to be effective.
HER2-negative
Refers to cancer cells that do not have an excess of the HER2 protein on their surface. This means targeted therapies designed to block HER2 are unlikely to be effective.
BRCA gene mutations
Changes in the BRCA1 or BRCA2 genes that can increase a person's risk of developing certain cancers, including breast, ovarian, and prostate cancers.
ACTION TIMELINE
2 EVENTS
MAR 3, 25
Submitted in House
COMMITTEE
MAR 3, 25
Referred to the House Committee on Oversight and Government Reform.
